PharVision Advisers’s Blue Bird Corp BLBD Stock Holding History

PharVision Advisers’s Portfolio BLBD Stock Details BLBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,411	Closed	-$348K	–	162
2025 Q4	$348K	Buy	+7,411	New	+$387K	0.18%	196

Other funds holding BLBD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PharVision Advisers's BLBD Position: Q1 2026 in Review

PharVision Advisers sold out of Blue Bird Corp (BLBD) in Q1 2026, closing a stake of 7,411 shares — an estimated $348K sold.

PharVision Advisers first reported a position in BLBD in Q4 2025 and held it in 1 quarter. The position peaked at $348K in Q4 2025. 288 funds tracked by Wall St. Rank hold BLBD as of Q1 2026.

PharVision Advisers reported no remaining Blue Bird Corp position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 7,411 Blue Bird Corp shares in Q1 2026, an estimated $348K.
PharVision Advisers first reported a position in Blue Bird Corp in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Blue Bird Corp position peaked at $348K in Q4 2025.
288 funds tracked by Wall St. Rank held Blue Bird Corp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.